Noble International Competitors and Similar CompaniesClear all

Noble International's competitors and similar companies include Paratek Pharmaceuticals, Noveome Biotherapeutics, Metabolon and InhibRx.

	Noble International Noble is a patient-centric product development company for the world's leading pharmaceutical brands.	Paratek Pharmaceuticals Paratek Pharmaceuticals is focused on the discovery, development, and commercialization of medicines designed to save lives and alleviate suffering.	Noveome Biotherapeutics Noveome Biotherapeutics is a clinical-stage biopharmaceutical company.	Metabolon Global leader in metabolomics for precision medicine, biomarker discovery, and advancing pharma & life sciences research.	InhibRx InhibRx is a clinical-stage biotechnology company developing a broad pipeline of novel biologic therapeutic candidates.
Founding Date	Founding Date 1994	Founding Date 1996	Founding Date 2000	Founding Date 2000	Founding Date 2017
Type	Type Private	Type Public	Type Private	Type Private	Type Public
Tags	Tags Healthcare Technology biotech pharma	Tags Healthcare Technology biotech drug development pharma	Tags Healthcare Technology biotech pharma	Tags Healthcare Technology biotech healthtech pharma	Tags Healthcare Technology biotech pharma therapy
Locations	Locations Orlando, US HQ	Locations Boston, US HQ King Of Prussia, US	Locations Pittsburgh, US HQ Clearwater, US	Locations Morrisville, US HQ Hallbergmoos, DE München, DE	Locations San Diego, US HQ
Employees	Employees 63	Employees 10123% increase	Employees 26	Employees 1911% increase	Employees 1531% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 127.8 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 233.1 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $160.3m (FY, 2022)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $1.8m (FY, 2023)
Net income	Net income N/A	Net income ($63.6m) (FY, 2022)	Net income N/A	Net income N/A	Net income ($241.4m) (FY, 2023)
Funding
Latest funding round	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 15m (about 7 years ago)	Latest funding round $ 15m (over 9 years ago)	Latest funding round N/A
Total funding raised	Total funding raised N/A	Total funding raised $ 93m	Total funding raised $ 17.7m	Total funding raised $ 95.4m	Total funding raised $ 43.6m